FSRH | COC – risks of different oestrogen and progesterone

22nd July 2016 by Louise Hudman

FSRH | COC – risks of different oestrogen and progesterone

This is a statement from the FSRH on a study recently published on risks with COC use. This study looks at how the different dose of oestrogen and how the different progesterone affect the risk of PE, CVA and MI. Bottom line – we should be advising women choosing the COC that a 20mcg ethinylestradiol/levonorgestrel pill may have lower thrombotic risks (though there is no such pill available in the UK at present).

The study showed that:

  • levonorgestrel containing pills have a lower risk of PE than desogestrel and gestodene containing pills.
  • 20mcg ethinylestradiol containing pills have a lower risk of PE, ischaemic CVA and MI than pills containing more oestrogen.

How significant is this?

The results are significant. However, the absolute levels of risk are low and the study didn’t look at the background risks in the population.


Join to view the rest of this content, as well as access all the benefits of joining NASGP.



Already a member? Login to view this content.


"Work as GP locum provides me both flexibility and autonomy together with great job satisfaction. However, there are some complexities one needs to address in starting out and doing everything right.

I've generally found answers to any issues I've had on the NASGP website – an excellent repository of very relevant information. The blog and magazines alone are almost worth the small costs of membership. The fact that NASGP is run by motivated fellow GPs gives me confidence in their guidance and advice.

LocumDeck makes my running things as a self-employed GP almost effortless - I don't think I would want to work without it. Invoicing is streamlined and the website is very user-friendly. After a busy week at work, the last thing you want is to spend hours on business admin. LocumDeck is a real timesaver.

Dr James O’Mahony

See the full list of features within our NASGP membership plans